Home › Funds › Kathmere Capital Management, LLC › GMED

Kathmere Capital Management, LLC position in GMED

GLOBUS MED INC · Health Care

Kathmere Capital Management, LLC reported holding 255,730 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$19.2M, representing 0.94% of its reported portfolio and ranking #23 among its reported holdings. Kathmere Capital Management, LLC has disclosed GMED holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)255.73K sh
Reported value held$19.15M
Portfolio Weight0.94%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kathmere Capital Management, LLC's GMED position evolved

Kathmere Capital Management, LLC first disclosed a stake in GMED in Q4 2024 at 279,176 shares (US$23.1M). The position peaked in Q4 2025 at 270,888 shares, worth US$23.7M. Across 8 filings, Kathmere Capital Management, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 255,730 shares valued at US$19.2M — a reduction of -15,767 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 279.18K $23.09M New
Q1 2025 279.18K $20.44M Hold
Q2 2025 279.18K $16.48M Hold
Q3 2025 279.33K $16.00M Hold
Q4 2025 270.89K $23.65M Reduce
Q1 2026 271.13K $23.36M Hold
Q2 2026 271.50K $21.45M Hold
Q3 2026 255.73K $19.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Kathmere Capital Management, LLC held GMED?

Kathmere Capital Management, LLC has disclosed GMED holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Kathmere Capital Management, LLC's current position in GMED?

As of Q3 2026, Kathmere Capital Management, LLC holds 255.73K shares of GMED (GLOBUS MED INC), valued at $19.15M, representing 0.94% of its reported portfolio and ranking #23.

Has Kathmere Capital Management, LLC been buying or selling GMED?

In the latest 13F filing (Q3 2026), Kathmere Capital Management, LLC reduced its position in GMED. The position peaked in Q4 2025 at 270.89K shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.